Press releases

Press release2021/01/18

Medivir publishes prospectus relating to the rights issue – including new financial information

Medivir AB (“Medivir” or “the Company”) announces that the prospectus relating to Medivir’s rights issue (the “Rights Issue”) has been approved...

Read more

Press release2021/01/13

Resolutions at the extraordinary general meeting in Medivir on 13 January 2021

Resolution regarding reduction of the share capital without cancellation of shares  The extraordinary general meeting in Medivir Aktiebolag (publ) on 13...

Read more

Press release2021/01/12

Medivir presents MIV-818 data at ASCO Gastrointestinal Cancers Symposium

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that a presentation entitled “Phase I study of the novel pro-drug...

Read more

Press release2021/01/11

Medivir enters into exclusive licensing agreement with IGM Biosciences for birinapant

Stockholm — Medivir AB (publ) (Nasdaq Stockholm: MVIR) today announced that it has entered into an exclusive licensing agreement, through which...

Read more